Ongoing Projects

ABAStroke sp. z o.o. is implementing a project co-financed by European Funds entitled Innovative Class IIa medical device for cognitive rehabilitation for stroke patients, which can be reimbursed in at least one European market under the European Funds for Małopolska 2021-2027 program, Priority 1. European funds for research and development and entrepreneurship, Action 1.2 Innovation vouchers for SMEs, project type A. Innovation vouchers for SMEs, co-financed by the European Regional Development Fund

The aim of the project is to create an innovative Class IIa medical device for cognitive rehabilitation for stroke patients, which can be reimbursed in at least one European market.

The project has been divided into two stages:

1. Conducting advanced analyses of MRI images of stroke patients using the ABAStroke application and comparing them with a control group. The aim of these analyses is to identify structural and functional changes in the brain that correlate with progress in cognitive rehabilitation. This will allow for a better understanding of rehabilitation mechanisms and determination of factors that have the greatest impact on improving cognitive functions in stroke patients.
2. Conducting comprehensive quality certification processes and certification as a Class IIa medical product. This will confirm that the created technology meets high safety and effectiveness standards, but most importantly, it is necessary for the innovative product to enter the market as a medical device and be reimbursed by payers for stroke patients.

Project value: 352,204.08 PLN

EU co-financing: 243,393.06 PLN

ABAStroke sp. z o.o. is implementing a project co-financed by European Funds entitled "ABAStroke - personalized mobile rehabilitation of post-stroke cognitive deficits" under the European Regional Development Fund Operational Program Smart Growth 2014-2020 action 1.1 Sub-measure 1.1.1 as part of the National Center for Research and Development "Fast Track" competition

The aim of the project is to develop an innovative solution, which will be an AI-based technology dedicated to the rehabilitation of cognitive functions in stroke patients.

EU co-financing: 4,593,946.80 PLN

Project: ABAStroke Dementia Prevention - Development of a medical device using generative artificial intelligence for personalized prevention of post-stroke dementia, implemented under the National Recovery and Resilience Plan Component D Efficiency, accessibility and quality of the health care system Investment D3.1.1 Comprehensive development of research in medical sciences and health sciences.

The project involves developing a medical device in the form of the "ABAStroke Dementia Prevention" mobile application, utilizing generative artificial intelligence for long-term dementia prevention in post-stroke patients. It is estimated that 30-40% of stroke patients may develop dementia within 5 years, posing a challenge to healthcare. The innovation lies in combining AI with cognitive therapy, providing support without the need for constant specialist supervision.

Project value: 5,302,974.00 PLN

Co-financing amount: 4,242,379.20 PLN